3rd Training School on ‘Liquid Biopsies in Hematological Malignancies – identification of immunotherapy biomarkers’

3rd Training School on ‘Liquid Biopsies in Hematological Malignancies – identification of immunotherapy biomarkers’

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Date: 30/06/2025, 01/07/2025 and 02/07/2025 (3 days)
Location of Training: Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba – Celas, 3000-548 Coimbra, Portugal 

Organisers: Ana Bela Sarmento-Ribeiro, Ana Cristina Gonçalves, Raquel Alves (FMUC/ULSC-CHUC); M. Helena Vasconcelos (i3S/FFUP), Rui Bergantim (i3S/FMUP/ULSJ).

We are happy to officially announce our 3rd IMMUNO-model Training School on “Liquid Biopsies in Hematological Malignancies – identification of immunotherapy biomarkers”, from 30th June to 2nd July 2025, at the Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

This training school aims to provide an introduction and comprehensive training in the role of liquid biopsies in diagnosis, prognosis, monitoring, and drug response evaluation, including drug resistance, in hematological malignancies. It will cover fundamental concepts, advanced strategies and techniques, practical approaches and clinical applications. Participants will attend lectures, engage in interactive panel discussions, and participate in hands-on sessions to enhance their understanding and skills in these cutting-edge fields.

Priority for places and reimbursement will be given to IMMUNO-model PhD students and young researchers (COST’s definition of Young Researchers and Innovators (YRIs) is those engaged in research under the age 40 years old). The next priority level will be given to maintain a good balance of: gender, age, country and institution of affiliation. Please indicate in your application if the YRI definition applies to you. Otherwise, priority will be given on a first-come, first-served basis.

More information will follow in the coming weeks and the application process will also open shortly.

Latest Updates

STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
Patients’ Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain April 23rd, at 4 pm CETLive on TEAMs platform Speakers Dr. Uzma Hassan, CRCL – The Lyon...
The @immunomodel COST Action workshop MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY, organized by @MarValesLab CNB-CSIC, brought together leading international experts...
IMMUNO-model released Annual report for Grant Period 3, in which activities and achievements of IMMUNO-model are summarized
We invite cancer patients, relatives, and caregivers to join our patient webinar, where we will explain the basics of immunotherapy, discuss current challenges, and highlight how patient involvement is essential...
We’re excited to share the latest addition to the IMMUNOmodel Knowledge Hub:👉 “Invasion/Chemotaxis-on-chip” by Devrim Pesen Okvur🔗 https://osf.io/yws9r/files/7sqye  This step-by-step protocol details how to study cell invasion and chemotaxis in 3D...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter